153 related articles for article (PubMed ID: 14501381)
1. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):595-600. PubMed ID: 14501381
[TBL] [Abstract][Full Text] [Related]
2. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
[TBL] [Abstract][Full Text] [Related]
3. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
5. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
Clark LC; Marshall JR
Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
[TBL] [Abstract][Full Text] [Related]
6. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Algotar AM; Stratton MS; Ahmann FR; Ranger-Moore J; Nagle RB; Thompson PA; Slate E; Hsu CH; Dalkin BL; Sindhwani P; Holmes MA; Tuckey JA; Graham DL; Parnes HL; Clark LC; Stratton SP
Prostate; 2013 Feb; 73(3):328-35. PubMed ID: 22887343
[TBL] [Abstract][Full Text] [Related]
7. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL
Trials; 2016 Aug; 17():400. PubMed ID: 27519183
[TBL] [Abstract][Full Text] [Related]
10. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
[TBL] [Abstract][Full Text] [Related]
11. SELECT: the selenium and vitamin E cancer prevention trial.
Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
Urol Oncol; 2003; 21(1):59-65. PubMed ID: 12684129
[TBL] [Abstract][Full Text] [Related]
12. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
Clark LC; Dalkin B; Krongrad A; Combs GF; Turnbull BW; Slate EH; Witherington R; Herlong JH; Janosko E; Carpenter D; Borosso C; Falk S; Rounder J
Br J Urol; 1998 May; 81(5):730-4. PubMed ID: 9634050
[TBL] [Abstract][Full Text] [Related]
13. A report of high-dose selenium supplementation: response and toxicities.
Reid ME; Stratton MS; Lillico AJ; Fakih M; Natarajan R; Clark LC; Marshall JR
J Trace Elem Med Biol; 2004; 18(1):69-74. PubMed ID: 15487766
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
[TBL] [Abstract][Full Text] [Related]
15. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
Duffield-Lillico AJ; Dalkin BL; Reid ME; Turnbull BW; Slate EH; Jacobs ET; Marshall JR; Clark LC;
BJU Int; 2003 May; 91(7):608-12. PubMed ID: 12699469
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
[TBL] [Abstract][Full Text] [Related]
17. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
Marshall JR
Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of plasma selenium levels and prostate cancer risk.
Li H; Stampfer MJ; Giovannucci EL; Morris JS; Willett WC; Gaziano JM; Ma J
J Natl Cancer Inst; 2004 May; 96(9):696-703. PubMed ID: 15126606
[TBL] [Abstract][Full Text] [Related]
19. Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).
Nicastro HL; Dunn BK
Nutrients; 2013 Apr; 5(4):1122-48. PubMed ID: 23552052
[TBL] [Abstract][Full Text] [Related]
20. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
